ArticleJournal of cellular and molecular medicine2024

Single low-dose decitabine as frontline therapy of acute myeloid leukaemia, with venetoclax salvage.

Ciprian Jitaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.